Home » Stocks » Obalon Therapeutics

Obalon Therapeutics, Inc. (OBLN)

Stock Price: $0.794 USD -0.033 (-3.99%)
Updated Aug 14, 2020 4:00 PM EDT - Market closed
After-hours: $0.780 -0.014 (-1.76%) Aug 14, 7:51 PM

Stock Price Chart

Key Info

Market Cap 6.14M
Revenue (ttm) 2.60M
Net Income (ttm) -18.07M
Shares Out 7.73M
EPS (ttm) -2.47
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 14, 2020
Last Price $0.794
Previous Close $0.827
Change ($) -0.033
Change (%) -3.99%
Day's Open 0.840
Day's Range 0.760 - 0.840
Day's Volume 654,998
52-Week Range 0.620 - 2.750

More Stats

Market Cap 6.14M
Enterprise Value 1.01M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 7.73M
Float 6.60M
EPS (basic) -1.79
EPS (diluted) -2.47
FCF / Share -2.16
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 476,692
Short Ratio 1.18
Short % of Float 5.24%
Beta -1.11
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 2.36
PB Ratio 0.83
Revenue 2.60M
Operating Income -17.79M
Net Income -18.07M
Free Cash Flow -16.72M
Net Cash 5.13M
Net Cash / Share 0.66
Gross Margin 14.75%
Operating Margin -683.25%
Profit Margin -694.10%
FCF Margin -642.45%
ROA -62.47%
ROE -232.16%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy 0
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Hold

Price Target

$0.75*
Low
0.75
Current: $0.794
High
0.75
Target: 0.75
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014
Revenue3.289.109.913.394.043.54
Revenue Growth-63.95%-8.2%192.19%-15.99%14.13%-
Gross Profit0.333.685.090.581.540.63
Operating Income-23.23-36.97-34.39-19.51-14.97-9.84
Net Income-23.68-37.38-34.77-20.47-15.55-9.88
Shares Outstanding4.711.901.670.420.060.05
Earnings Per Share-5.03-19.64-20.80-48.47-271.40-186.10
Operating Cash Flow-22.87-29.43-30.62-19.37-11.39-9.91
Capital Expenditures-0.19-1.28-1.04-0.35-0.13-0.27
Free Cash Flow-23.06-30.71-31.67-19.72-11.53-10.18
Cash & Equivalents14.0623.7444.4075.4812.5319.24
Total Debt1.139.939.929.889.844.88
Net Cash / Debt12.9313.8134.4865.592.6914.37
Assets20.3930.3953.1078.7814.2220.72
Liabilities4.5417.2817.9914.4714.665.75
Book Value15.8513.1135.1164.31-55.14-39.86
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Obalon Therapeutics, Inc.
Country United States
Employees 34
CEO Andrew P. Rasdal

Stock Information

Ticker Symbol OBLN
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: OBLN
IPO Date October 6, 2016

Description

Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallow able capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. As of February 27, 2020, it had three company-managed retail treatment centers in California. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.